Kazia set to raise $4m to improve cancer trials
MELBOURNE: Kazia Therapeutics will raise $4 million to improve its GDC-0084 and Cantrixil cancer programs.
MELBOURNE: Kazia Therapeutics will raise $4 million to improve its GDC-0084 and Cantrixil cancer programs.
FEATURED
Tiny home community set to be created in middle of city
200-unit housing complex for vets, seniors and health-care workers planned
Affordable and intergenerational development will have 71 units
Multigenerational disability and social housing build-to-rent gets green light
IKEA donates first tiny home to support healing for homeless seniors
Best retirement housing design for Global Awards shortlisted
INNOVATION
